(ALHC) Alignment Healthcare - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US01625V1044

ALHC: Medicare Advantage, Healthcare Plans, Senior Care

Alignment Healthcare, Inc. operates a consumer-centric healthcare platform tailored for seniors in the United States, focusing on delivering personalized healthcare experiences through its Medicare Advantage plans. Founded in 2013 and headquartered in Orange, California, the company leverages technology and data analytics to improve health outcomes for its members. Alignment Healthcare emphasizes value-based care, offering a range of benefits and services designed to address the unique needs of seniors, including chronic disease management, telehealth services, and social determinants of health support. The company has established partnerships with providers and health systems to enhance care coordination and accessibility. For more information, visit their website at https://www.alignmenthealth.com.

Ticker Symbol: ALHC | Exchange: NASDAQ | Type: Common Stock | Country Origin: United States | GICS Sub Industry: Health Care Services

3-Month Forecast: Based on and , Alignment Healthcares stock (ALHC) is expected to trade in a range of $16.65 to $18.50 over the next three months, with an average volume of 3,005,527 shares. The stock is currently priced at $17.52, with a 20-day moving average of $18.50 and a 50-day moving average of $16.65. The ATR of 1.05 suggests moderate volatility. On the fundamental side, the companys market cap of $3,786.76M and P/S ratio of 1.40 indicate a relatively high valuation compared to its peers. The lack of P/E and RoE data may signal profitability challenges. Overall, the stock is likely to experience sideways movement with potential upside if it breaks above the 20-day SMA resistance level.

Additional Sources for ALHC Stock

ALHC Stock Overview

Market Cap in USD 3,461m
Sector Healthcare
Industry Healthcare Plans
GiC Sub-Industry Health Care Services
IPO / Inception 2021-03-26

ALHC Stock Ratings

Growth Rating 8.96
Fundamental -1.67
Dividend Rating 0.0
Rel. Strength 238
Analysts 4.09/5
Fair Price Momentum 18.62 USD
Fair Price DCF -

ALHC Dividends

No Dividends Paid

ALHC Growth Ratios

Growth Correlation 3m 82.5%
Growth Correlation 12m 95.2%
Growth Correlation 5y -42.3%
CAGR 5y 0.57%
CAGR/Max DD 5y 0.01
Sharpe Ratio 12m 1.32
Alpha 233.42
Beta 0.841
Volatility 65.65%
Current Volume 3419.9k
Average Volume 20d 2988.4k
What is the price of ALHC stocks?
As of May 01, 2025, the stock is trading at USD 17.72 with a total of 3,419,876 shares traded.
Over the past week, the price has changed by -3.17%, over one month by -4.83%, over three months by +15.14% and over the past year by +244.08%.
Is Alignment Healthcare a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Alignment Healthcare is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -1.67 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALHC as of May 2025 is 18.62. This means that ALHC is currently overvalued and has a potential downside of 5.08%.
Is ALHC a buy, sell or hold?
Alignment Healthcare has received a consensus analysts rating of 4.09. Therefor, it is recommend to buy ALHC.
  • Strong Buy: 6
  • Buy: 1
  • Hold: 3
  • Sell: 1
  • Strong Sell: 0
What are the forecast for ALHC stock price target?
According to ValueRays Forecast Model, ALHC Alignment Healthcare will be worth about 20.8 in May 2026. The stock is currently trading at 17.72. This means that the stock has a potential upside of +17.21%.
Issuer Forecast Upside
Wallstreet Target Price 17.8 0.3%
Analysts Target Price 17.8 0.3%
ValueRay Target Price 20.8 17.2%